Abstracts Archive - Page 2418 of 2607 - ACR Meeting Abstracts

Abstract Number: 181 • 2013 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Quality Measure Results In a Large Managed Care Population
Roxanne Meyer¹, Lorie A. Ellis², Susan C. Bolge³, Andrew Howe⁴ and Yunping Zhou⁴, ¹Janssen Scientific Affairs, LLC, Horsham, NY, ²Health Economics & Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, ³Janssen Scientific Affairs, LLC, Horsham, PA, ⁴Comprehensive Health Insights, Louisville, KY
Background/Purpose: Improvement in quality of care is of growing interest to both physicians and payers. Both the American College of Rheumatology and National Quality Forum…
Abstract Number: 182 • 2013 ACR/ARHP Annual Meeting
National Quality Forum Measures Among Rheumatoid Arthritis Patients In a Large Managed Care Population
Roxanne Meyer¹, Lorie A. Ellis², Susan C. Bolge³, Joseph Tkacz⁴, Peter Kardel⁴ and Charles Ruetsch⁴, ¹Janssen Scientific Affairs, LLC, Horsham, NY, ²Health Economics & Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, ³Janssen Scientific Affairs, LLC, Horsham, PA, ⁴Health Analytics, LLC, Columbia, MD
Background/Purpose: The American College of Rheumatology and National Quality Forum (NQF) recommend monitoring quality measures among rheumatoid arthritis (RA) patients. This study describes the proportion…
Abstract Number: 183 • 2013 ACR/ARHP Annual Meeting
The Performance Of a Point Of Care Test For Detection Of Anti-Mutated Citrullinated Vimentin and Rheumatoid Factor In Early Rheumatoid Arthritis
Preeda Rojanasantikul¹, Prapa Pattrapornpisut², Kulvara Anuruckparadorn³ and Wanruchada Katchamart¹, ¹Division of Rheumatology, Department of Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, ²Department of Internal Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, ³Department of Transfusion Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Background/Purpose: Besides rheumatoid factor (RF), anti-cyclic citrullinated peptide antibody (ACPA), a newer serologic marker, was added to the new American College of Rheumatology (ACR)/European League…
Abstract Number: 184 • 2013 ACR/ARHP Annual Meeting
Are Physician Gender, Age and Clinical Experience Associated With Discrepancy In Global Disease Score In Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis? Data From The Nationwide Danbio Registry
Cecilie Lindstrom Egholm¹, Niels Steen Krogh², Lene Dreyer³, Torkell Ellingsen⁴, Bente Glintborg⁵, Marcin Kowalski⁶, Tove Lorenzen⁷, Ole Rintek Madsen⁸, Henrik Nordin^9,10, Claus Rasmussen¹¹ and Merete L. Hetland¹², ¹Regional Research Unit, Region Zealand, Roskilde, Denmark, ²ZiteLab ApS, Copenhagen, Denmark, ³Internal Medicine - Rheumatology Section, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark, ⁴Department of Internal Medicine, Diagnostic Centre Region Hospital Silkeborg Denmark, 8600 Silkeborg, Denmark, ⁵Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Glostrup, Denmark, ⁶Aalborg University Hospital, Aalborg, Denmark, ⁷Department of Rheumatology, Region Hospital Silkeborg, Silkeborg, Denmark, ⁸Department of Rheumatology, Copenhagen University Hospital in Gentofte, Copenhagen, Denmark, ⁹Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Denmark, ¹⁰DANBIO, On behalf of Depts of Rheumatology, North, South, Central, Zealand and Capital Region, Copenhagen, Denmark, ¹¹Vendsyssel Teaching Hospital/Aalborg University, Hjoerring, Denmark, ¹²Copenhagen University Hospital Glostrup, Copenhagen, Denmark
Background/Purpose: A global estimate on a 100 mm Visual Analogue Scale (VAS) assessed by patients (PATGL) and physicians (DOCGL) is commonly used to measure disease…
Abstract Number: 185 • 2013 ACR/ARHP Annual Meeting
No Secular Trends In Real Live Radiographic Progression Of Rheumatoid Arthritis In Recent Year
Miriam Gärtner¹, Farideh Alasti², Gabriela Supp¹, Josef S. Smolen³ and Daniel Aletaha¹, ¹Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ²Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ³Department of Rheumatology, Medical University of Vienna and Hietzing Hospital, Vienna, Austria
Background/Purpose: Progression of joint damage as measured radiographically is a hallmark of rheumatoid arthritis (RA), and its reduction a key claim for traditional and novel…
Abstract Number: 186 • 2013 ACR/ARHP Annual Meeting
Delay In Consultation and Starting Disease Modifying Anti-Rheumatic Drugs In Patients With Rheumatoid Arthritis In Argentina. How Early Arthritis Clinics Impact On Health Barriers?
Natalia Zamora¹, Christian A. Waimann², Maria Florencia Marengo², Gustavo Citera¹, Amelia Granel³, Ana Inés Marcos³, Emilio Buschiazzo⁴, Ricardo V. Juarez⁵, Dora Pereira⁶, Gisela Pendón⁶, Andrea D'Orazio⁷, Mariana Salcedo⁸, Judith Sarano⁹, María Victoria Collado⁹, Graciela Gómez¹⁰, Alejandra Medina¹¹, María Eugenia Lara¹², Juan C. Barreira¹², María Alicia Lázaro¹³, Alejandra Cusa¹³, Luciana González Lucero¹⁴, María Silvia Yacuzzi¹⁴, Raúl Nicolas Martínez¹⁵ and Pablo Arturi¹⁶, ¹Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³Rheumatology, Hospital San Roque de Gonnet, La Plata, La Plata, Argentina, ⁴Rheumatology, Hospital Señor del Milagro, Salta, Argentina, ⁵Rheumatology Section, Hospital Señor del Milagro, Salta, Argentina, ⁶Hospital Ricardo Gutierrez, La Plata, La Plata, Argentina, ⁷rheumatology, Hospital Municipal de agudos Dr. Leonidas Lucero, Bahía Blanca, Argentina, ⁸Consultorio Privado, San Nicolás, Argentina, ⁹Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, ¹⁰Rheumatology, Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, ¹¹Hospital General de Agudos "Dr. E. Tornu", Ciudad Autónoma de Buenos Aires, Argentina, ¹²Rheumatology, British Hospital, Buenos Aires, Argentina, ¹³Hospital central de San isidro Dr A. Posse, San Isidro, Argentina, ¹⁴Hospital Angel Cruz Padilla, San Miguel de Tucumán, Argentina, ¹⁵Hospital Angel C. Padilla de San Miguel de Tucumán, San Miguel de Tucumán, Argentina, ¹⁶Hospital Italiano de La Plata, La Plata, Argentina
Background/Purpose: An early and intensive treatment has become the cornerstone in the treatment of Rheumatoid Arthritis (RA). For this reason, an early consult with a rheumatologist is…
Abstract Number: 188 • 2013 ACR/ARHP Annual Meeting
Can MDHAQ/RAPID3 Be Used In Usual Care Of Patients With Systemic Lupus Erythematosus?
Narender Annapureddy¹, Theodore Pincus¹, Joel A. Block² and Meenakshi Jolly¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Section of Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Disease-specific patient reported outcome (PRO) tools are uniquely informative for the management of systemic lupus erythematosus (SLE) patients. However, it is difficult to incorporate…
Abstract Number: 190 • 2013 ACR/ARHP Annual Meeting
A Meta-Analysis and Systematic Literature Review: Effect Of The Method Used To Measure Adherence In Rheumatoid Arthritis On Its Rate, and Evaluation Of Associated Factors
Anat Scheiman-Elazary¹, Cortney Shourt², M. Cameron Hay³ and Daniel Furst⁴, ¹Rheumatology, Rheumatology UCLA, Los Angeles, CA, ²Rheumatology UCLA, Los Angeles, CA, ³Anthropology Miami University, Oxford, OH, ⁴Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA
Background/Purpose: Adherence reported in the literature for RA varies widely (49.5-98%)1. This variability may result in part from different methods used to measure adherence. Our…
Abstract Number: 191 • 2013 ACR/ARHP Annual Meeting
Does Specific Joint Involvement In Rheumatoid Arthritis Patients Predict Patient Reported Outcomes? Implications For Clinical Practice
Regan Arendse¹, William G. Bensen², Andrew Chow³, Jude F. Rodrigues⁴, Sanjay Dixit⁵, Dalton E. Sholter⁶, Philip Baer⁷, Milton F. Baker⁸, Denis Choquette⁹, Isabelle Fortin¹⁰, Algis Jovaisas¹¹, Emmanouil Rampakakis¹², John S. Sampalis¹², Francois Nantel¹³, Susan M. Otawa¹⁴, May Shawi¹⁵ and Allen J. Lehman¹⁴, ¹University of Saskatchewan, Saskatoon, SK, Canada, ²Department of Medicine, Division of Rheumatology, Clinical Professor, McMaster University, Hamilton, ON, Canada, ³University of Toronto, McMaster University, Credit Valley Rheumatology, Mississauga, ON, Canada, ⁴Rheumatology, Windsor, ON, Canada, ⁵McMaster University, Hamilton, ON, Canada, ⁶Rheumatology Associates, Edmonton, AB, Canada, ⁷Private Practice, Scarborough, ON, Canada, ⁸University of Victoria, Victoria, BC, Canada, ⁹Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, ¹⁰Centre de rhumatologie de l'est du Québec (CREQ), Rimouski, QC, Canada, ¹¹Division of Rheumatology, University of Ottawa, Ottawa, ON, Canada, ¹²JSS Medical Research, Montreal, QC, Canada, ¹³Janssen Inc., Toronto, ON, Canada, ¹⁴Medical Affairs, Janssen Inc., Toronto, ON, Canada, ¹⁵Medical Affairs, Janssen Canada Inc, Toronto, ON, Canada
Background/Purpose: Assessment of functional (dis)ability in rheumatoid arthritis (RA) is subject to patient judgment when appraising their ability to do daily activities. The aim of…
Abstract Number: 192 • 2013 ACR/ARHP Annual Meeting
Can Routine Assessment Of Patient Index Data (RAPID)3 Be Used As a Patient Reported Assessment Tool For Patients With Ankylosing Spondylitis?
Muhammet Cinar¹, Sedat Yilmaz², Fatma Ilknur Cinar³, Suleyman Serdar Koca⁴, Hakan Erdem⁵, Salih Pay⁵, Yusuf Yazici⁶, Ayhan Dinc⁷ and Ismail Simsek², ¹Rheumatology, Gulhane School of Medicine, Ankara, Turkey, ²Gulhane School of Medicine, Ankara, Turkey, ³Gulhane Military Medical Academy, School of Nursing, Ankara, Turkey, ⁴Department of Rheumatology, Faculty of Medicine, Firat University, Elazig, Turkey, ⁵Division of Rheumatology, Gulhane School of Medicine, Ankara, Turkey, ⁶Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ⁷Rheumatology, Patio Clinic, Ankara, Turkey
Background/Purpose: The assessment of disease activity in rheumatology is essential in both clinical trials and practice. The patient reported questionnaires have shown to reflect disease…
Abstract Number: 193 • 2013 ACR/ARHP Annual Meeting
Physician Variability In Rheumatoid Patients Not Receiving Biologics Or Non-Biologic Dmards: Implications For Quality Reporting
Dimitrios A. Pappas¹, Lang Chen², Leslie R. Harrold³, George W. Reed⁴, Joel M. Kremer⁵, Jeffrey D. Greenberg⁶ and Jeffrey R. Curtis⁷, ¹Department of Medicine, Division of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, NY, ²Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³University of Massachusetts Medical School, Worcester, MA, ⁴Corrona, LLC., Southborough, MA, ⁵Center for Rheumatology, Albany Medical College, Albany, NY, ⁶Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, NY, ⁷University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, Birmingham, AL
Background/Purpose: Current quality of care guidelines recommend that all patients with Rheumatoid Arthritis (RA) be treated with biologic and/or non-biologic (nb) DMARDs. However, some RA…
Abstract Number: 194 • 2013 ACR/ARHP Annual Meeting
Team Managed Care From a Patient’s Perspective: A Study Of Biological Patients At a Canadian Centre
Dawn Heap¹, Margaret Saldanha¹, Melissa Deamude¹, Cynthia Mech², Helena Ross¹, Kathy Kislinsky¹, Lauri Vanstone³, Arthur N. Lau⁴ and William G. Bensen⁵, ¹Dr. William G. Bensen, Rheumatology Health Team, St. Joseph's Hospital Hamilton, Hamilton, ON, Canada, ²Dr. William G. Bensen, Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, ³Dr. William Bensen Rheumatology Biologic Clinic, Rheumatology Health Team, Hamilton, ON, Canada, ⁴Rheumatology and Clinical Epidemiology, Division of Rheumatology, McMaster University, Hamilton, ON, Canada, ⁵Department of Medicine, Division of Rheumatology, Clinical Professor, McMaster University, Hamilton, ON, Canada
Background/Purpose: In Canada, there is a widening care gap in Inflammatory Arthritis due to the increased aging population, higher disease prevalence, dwindling numbers of practicing…
Abstract Number: 195 • 2013 ACR/ARHP Annual Meeting
Major Cost Savings Associated With Reduced Biologic Dosing Frequency In Inflammatory Arthritis
Claire-Louise Murphy¹, Miriam O'Sullivan², Sohail Awan³, Shawn Chavrimootoo⁴, Clara Bannon³, Linzi Martin², Trevor Duffy², Eithne Murphy² and Maurice Barry², ¹Rheumatology, Connolly hospital, Dublin 15, Dublin, Ireland, ²Rheumatology, Connolly hospital, Dublin, Ireland, ³Blanchardstown, Connolly hospital, Dublin, Ireland, ⁴rheumatology, Connolly hospital, Dublin, Ireland
Background/Purpose: Biologic agents are highly effective in Inflammatory Arthritis (IA) but are extremely expensive. A sustained reduction in biologic dosing frequency would lead to major…
Abstract Number: 196 • 2013 ACR/ARHP Annual Meeting
Uptake Of The American College Of Rheumatology’s Rheumatology Clinical Registry: Quality Measure Summary Data
Jinoos Yazdany¹, Salahuddin Kazi², Rachel Myslinski³ and Melissa Francisco⁴, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX, ³Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, ⁴Registries & Health Informatics, American College of Rheumatology, Atlanta, GA
Background/Purpose: The RCR provides ACR members with an infrastructure for quality reporting related to rheumatoid arthritis, gout, osteoarthritis, osteoporosis, and drug safety. Currently in its…
Abstract Number: 139 • 2013 ACR/ARHP Annual Meeting
Pain and Other Symptoms During The Childhood Of Fibromyalgia Patients
Robert S. Katz¹, Alexandra Small², Ben J. Small³ and Susan Shott⁴, ¹Rush Medical College, Chicago, IL, ²University of Illinois Medical School, Chicago, IL, ³Rush University Medical School, Chicago, IL, ⁴Rush University Medical Center, Chicago, IL
Background/Purpose: We investigated the severity of pain and other symptoms during childhood, before age 12 and before age 18, that might be related to fibromyalgia…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].